EZH2 and glioblastoma: Studies provide evidence of elevated EZH2 expression in various cancer types, such as breast cancer, glioblastoma, ovarian cancer, gastric cancer, prostate cancer, esophageal cancer, anaplastic thyroid carcinoma, and nasopharyngeal carcinoma [14,15,16,17,19].